Hercules Company Profile

19:36 EST 16th December 2018 | BioPortfolio

Founded in 1912, Hercules Incorporated manufactures and markets chemical specialties globally used in making a variety of products for home, office, and industrial markets. Our portfolio of businesses consists of two major operating segments: Aqualon Group and the Paper Technologies and Ventures Group.


1313 North Market Street
United States of America


Phone: (302) 594-5000
Fax: (302) 594-5400

News Articles [9 Associated News Articles listed on BioPortfolio]

Tricida enters $100mm loan agreement with Hercules; gets $25mm up front

Tricida Inc. entered a $100mm venture debt agreement with Hercules Capital. The company drew down an initial $25mm up front, with anther $50mm available subject to the achievement of certain milestone...

Merrimack enters $25mm debt facility with Hercules; draws down $15mm up front

Merrimack Pharmaceuticals Inc. (therapies for biomarker-defined cancers) entered a $25mm debt facility with Hercules Capital. The company received $15mm up front and will receive the remaining $10mm i...

Acacia Pharma secures $30 million funding

Provided by Hercules Technology Growth Capital, the funds will support the intended commercialisation of Barhemsys for post-operative nausea and vomiting in the US

Hercules Capital Receives Stockholder Approval to Reduce Its Asset Coverage Requirement to 150%

Received a “For” Recommendation from both Institutional Shareholders Services Inc. (“ISS”) and Glass, Lewis & Co. Hercules Capital, Inc. (NYSE: HTGC) (“He...

TransEnterix agrees to $40mm Hercules term loan; draws down $20mm immediately

TransEnterix Inc. (minimally invasive robotic surgical robotic systems) entered a debt financing agreement with Hercules Capital, which will provide an aggregate principal amount up to $40mm. In the t...

New charity-industry initiative to pioneer novel approach to Health Technology Assessment

‘HERCULES’ project will for the first time generate and share critical disease level data across an entire condition on behalf of all collaborating companies, simplifying all future submissionsNew...

Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)

    Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) CHMP recommends approval of Cablivi(TM) (caplacizumab) First therapeutic to receive positive...

Hercules Capital Proudly Announces Eight Portfolio Companies Have Completed or Announced an IPO or M&A Liquidity Event Year-to-Date 2018

Hercules’ Leading Originations Platform Continues to Finance Some of the Most Promising Innovative and Disruptive Venture-Backed Companies in the Market ...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Advanced Hadamard-encoded editing of seven low-concentration brain metabolites: Principles of HERCULES.

To demonstrate the framework of a novel Hadamard-encoded spectral editing approach for simultaneously detecting multiple low-concentration brain metabolites in vivo at 3T.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

The primary objective of this study was to demonstrate pharmacokinetic similarity of Mylan trastuzumab (Hercules) versus EU-approved Herceptin® and US-licensed Herceptin® and pharmacokin...

Study of Efficacy and Safety of Hercules(Myl1401O Mylan Trastuzumab) + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.

A multicenter, double-blind, randomized, parallel-group, Phase III study of the efficacy and safety of Hercules( Myl 1401O, Mylan Trastuzumab) plus taxane versus Herceptin® plus taxane as...

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

The objective of this study is to evaluate long-term safety and efficacy of caplacizumab, to evaluate safety and efficacy of repeated use of caplacizumab and to characterize long term impa...

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis

The purpose of this study is to determine whether the Herculink Elite Renal Stent System is safe and effective in the treatment of renal artery stenosis in patients with less than optimal ...

Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults

Background: Falls are a problem among the elderly population, it is known that currently about 30% of people over 65 years falls every year. The European Union estimates a cost of € 281 ...

Companies [8 Associated Companies listed on BioPortfolio]

Little Hercules Foundation and Team Joseph

Little Hercules Foundation is a registered, non-profit 501(c)(3) organization based in Dublin, Ohio. Little Hercules Foundation got its start in January 2013 when three moms, two ...

Hercules Capital, Inc.

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-gr...


Founded in 1912, Hercules Incorporated manufactures and markets chemical specialties globally used in making a variety of products for home, office, and industrial markets. Our portfolio of businesses...

Bio-Rad Laboratories


Hercules Technology Growth Capital, Inc.

Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stag...

More Information about "Hercules" on BioPortfolio

We have published hundreds of Hercules news stories on BioPortfolio along with dozens of Hercules Clinical Trials and PubMed Articles about Hercules for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hercules Companies in our database. You can also find out about relevant Hercules Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record